The Scripps Research Institute will get $20 million over five years from the National Institutes of Health (NIH) to study how drug resistance develops in HIV, according to a Scripps statement. The goal is to develop new HIV treatments. The NIH grant creates a new consortium, the HIV Interaction and Viral Evolution (HIVE) Center. Researchers from across the country will collaborate as part of the HIVE Center, which also includes scientists from both the Florida and California campuses of Scripps.

To read the statement, click here.